An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209485
Company: LUPIN LTD

Products on ANDA 209485

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 209485

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/28/2022	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/209485Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/29/2025	SUPPL-9	Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 209485

MIRABEGRON

TABLET, EXTENDED RELEASE;ORAL; 25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215948	ALKEM LABS LTD
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	218172	ASCENT PHARMS INC
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	209485	LUPIN LTD
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	218543	MSN
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	217989	QILU
MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	209488	ZYDUS PHARMS
MYRBETRIQ	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	202611	APGDI

TABLET, EXTENDED RELEASE;ORAL; 50MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215948	ALKEM LABS LTD
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	218172	ASCENT PHARMS INC
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	209485	LUPIN LTD
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	218543	MSN
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	217989	QILU
MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	209488	ZYDUS PHARMS
MYRBETRIQ	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	202611	APGDI

Top